A detailed history of Federated Hermes, Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 13,109 shares of AGIO stock, worth $451,736. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,109
Previous 13,394 2.13%
Holding current value
$451,736
Previous $577,000 0.87%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$41.19 - $49.72 $11,739 - $14,170
-285 Reduced 2.13%
13,109 $582,000
Q2 2024

Aug 08, 2024

BUY
$27.55 - $48.83 $30,525 - $54,103
1,108 Added 9.02%
13,394 $577,000
Q1 2024

May 14, 2024

BUY
$21.32 - $34.81 $25,989 - $42,433
1,219 Added 11.01%
12,286 $359,000
Q4 2023

Jan 31, 2024

SELL
$19.97 - $24.53 $37,323 - $45,846
-1,869 Reduced 14.45%
11,067 $246,000
Q2 2023

Aug 14, 2023

SELL
$21.38 - $29.19 $49,772 - $67,954
-2,328 Reduced 15.25%
12,936 $366,000
Q1 2023

May 08, 2023

BUY
$21.74 - $30.93 $59,958 - $85,304
2,758 Added 22.05%
15,264 $350,000
Q4 2022

Feb 13, 2023

SELL
$24.81 - $31.52 $138,985 - $176,575
-5,602 Reduced 30.94%
12,506 $351,000
Q3 2022

Nov 14, 2022

SELL
$19.51 - $34.14 $7.01 Million - $12.3 Million
-359,052 Reduced 95.2%
18,108 $512,000
Q2 2022

Aug 15, 2022

BUY
$17.06 - $31.42 $6.43 Million - $11.9 Million
377,160 New
377,160 $8.36 Million
Q1 2022

May 13, 2022

SELL
$26.68 - $34.81 $3,735 - $4,873
-140 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$29.58 - $49.78 $604,378 - $1.02 Million
-20,432 Reduced 99.32%
140 $5,000
Q3 2021

Nov 15, 2021

BUY
$41.92 - $58.18 $6,539 - $9,076
156 Added 0.76%
20,572 $949,000
Q2 2021

Aug 16, 2021

BUY
$52.06 - $61.27 $1.06 Million - $1.25 Million
20,408 Added 255100.0%
20,416 $1.13 Million
Q3 2018

Nov 13, 2018

SELL
$71.67 - $91.95 $3.35 Million - $4.3 Million
-46,786 Reduced 99.98%
8 $1,000
Q2 2018

Aug 10, 2018

SELL
$73.22 - $99.55 $1.64 Million - $2.23 Million
-22,366 Reduced 32.34%
46,794 $3.94 Million
Q1 2018

May 09, 2018

BUY
$59.83 - $86.53 $3.59 Million - $5.2 Million
60,067 Added 660.59%
69,160 $5.66 Million
Q4 2017

Feb 14, 2018

SELL
$52.12 - $72.33 $978,969 - $1.36 Million
-18,783 Reduced 67.38%
9,093 $0
Q3 2017

Nov 13, 2017

BUY
$54.89 - $67.12 $1.53 Million - $1.87 Million
27,876
27,876 $1.86 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.89B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.